80
Participants
Start Date
May 7, 2020
Primary Completion Date
March 1, 2026
Study Completion Date
May 31, 2028
Eltrombopag
Between 12 and 17yo (adult dose of 150mg) Between 6 and 11yo (75 mg) Between 3 and 5 yo (2.5 mg/kg)
Cyclosporine
Day 1 to start of h-ATG: 2mg/kg/day by mouth (All subjects) Start of h-ATG to Month 6: 3 mg/kg/dose by mouth administered every 12 hours (12yo and above) 6 mg/kg/dose by mouth administered every 12 hours (less than 12yo) Month 6 to Month 24: Dosing to be adjusted based on response
Horse-Anti-thymocyte-Globulin
h-ATG at a dose of 40 mg/kg/day for 4 days (intravenously for approximately 4 hours daily) Note: Omitted in patients who have achieved a complete response at the initial NIH visit after initiating oral treatment remotely
RECRUITING
National Institutes of Health Clinical Center, Bethesda
National Heart, Lung, and Blood Institute (NHLBI)
NIH